Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.

Cancer control : journal of the Moffitt Cancer Center - 1 Apr 2015

Macaulay Robert J

Abstract excerpt

BACKGROUND: Progress in molecular oncology during the last decade has enabled investigators to more precisely define and group gliomas. The impacts of isocitrate dehydrogenase (IDH) mutation (mut) status and other molecular markers on the classification, prognostication, and management of diffuse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Oligodendroglioma
Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Glioma

Share to Glutarates

Share to Isocitrate Dehydrogenase

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 26068765
DOI: 10.1177/107327481502200211

Genes

IDH1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26068765-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.PMID 26068765Read ↗

Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.Semantic proximity Read ↗

IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.Semantic proximity Read ↗

IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse GliomasSemantic proximity Read ↗

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.Semantic proximity Read ↗

Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse GliomasSemantic proximity Read ↗

Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing.Semantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Perspectives on IDH Mutation in Diffuse Gliomas.Semantic proximity Read ↗

Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Semantic proximity Read ↗

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Semantic proximity Read ↗

Pathology and genetics of diffuse gliomas in adults.Semantic proximity Read ↗

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.